Anika Therapeutics | Creditori Commerciali

Prezzo Delle Azioni
14.15
Cambio Giornaliero
-0.17 -1.19%
Mensile
41.22%
Annuale
-17.73%
Q1 Previsione
13.92




Creditori Commerciali Cambiamento Data
Abbott USD 4.12B 183M 2025-09
Agenus USD 85.29M 10.89M 2025-09
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 12.02M 20K 2025-09
Insmed USD 79.91M 316K 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 11.99B 2.37B 2025-12
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
MacroGenics USD 5.94M 1.28M 2025-09
Merit Medical Systems USD 60.55M 4.19M 2025-12
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Smith & Nephew USD 1.19B 73M 2025-12
Stryker USD 1.5B 56M 2025-09
Surmodics USD 2.79M 400K 2024-09
Veracyte USD 4.59M 916K 2025-12
Xencor USD 10.83M 1.75M 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12


Anika Therapeutics Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.